Abstract
Hypopituitarism in adult life is commonly acquired and the main causes are known as pituitary tumors and/or their treatments. Since there are new insights into the etiology of hypopituitarism and presence of differences in various populations, more studies regarding causes of hypopituitarism are needed to be done in different ethnic groups with sufficient number of patients. Therefore, we performed a multi-center database study in Turkish population investigating the etiology of hypopituitarism in 773 patients in tertiary care institutions. The study was designed and coordinated by the Pituitary Study Group of SEMT (The Society of Endocrinology and Metabolism of Turkey). Nineteen tertiary reference centers (14 university hospitals and 5 training hospitals) from the different regions of Turkey participated in the study. It is a cross-sectional database study, and the data were recorded for 18 months. We mainly classified the causes of hypopituitarism as pituitary tumors (due to direct effects of the pituitary tumors and/or their treatments), extra-pituitary tumors and non-tumoral causes. Mean age of 773 patients (49.8 % male, 50.2 % female) was 43.9 ± 16.1 years (range 16–84 years). The most common etiology of pituitary dysfunction was due to non-tumoral causes (49.2 %) among all patients. However, when we analyze the causes according to gender, the most common etiology in males was pituitary tumors, but the most common etiology in females was non-tumoral causes. According to the subgroup analysis of the causes of hypopituitarism in all patients, the most common four causes of hypopituitarism which have frequencies over 10 % were as follows: non-secretory pituitary adenomas, Sheehan’s syndrome, lactotroph adenomas and idiopathic. With regard to the type of hormonal deficiencies; FSH/LH deficiency was the most common hormonal deficit (84.9 % of the patients). In 33.8 % of the patients, 4 anterior pituitary hormone deficiencies (FSH/LH, ACTH, TSH, and GH) were present. Among all patients, the most frequent cause of hypopituitarism was non-secretory pituitary adenomas. However, in female patients, present study clearly demonstrates that Sheehan’s syndrome is still one of the most important causes of hypopituitarism in Turkish population. Further, population-based prospective studies need to be done to understand the prevalence and incidence of the causes of hypopituitarism in different countries.
Similar content being viewed by others
References
T. Rosen, B.A. Bengtsson, Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336, 285–288 (1990)
K. Stochholm, C.H. Gravholt, T. Laursen, P. Laurberg, M. Andersen, L.O. Kristensen, U. Feldt-Rasmussen, J.S. Christiansen, M. Frydenberg, A. Green, Mortality and GH deficiency: a nationwide study. Eur. J. Endocrinol. 157, 9–18 (2007)
K. Stochholm, T. Laursen, A. Green, P. Laurberg, M. Andersen, L.O. Kristensen, U. Feldt-Rasmussen, J.S. Christiansen, M. Frydenberg, C.H. Gravholt, Morbidity and GH deficiency: a nationwide study. Eur. J. Endocrinol. 158, 447–457 (2008)
J.W. Tomlinson, N. Holden, R.K. Hills, K. Wheatley, R.N. Clayton, A.S. Bates, M.C. Sheppard, P.M. Stewart, Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357, 425–431 (2001)
A.S. Bates, W. Van’t Hoff, P.J. Jones, R.N. Clayton, The effect of hypopituitarism on life expectancy. J. Clin. Endocrinol. Metab. 81, 1169–1172 (1996)
P.H. Sonksen, Replacement therapy in hypothalamo-pituitary insufficiency after childhood: management in the adult. Horm. Res. 33(Suppl 4), 45–51 (1990)
M.L. Vance, Hypopituitarism. N. Engl. J. Med. 330, 1651–1662 (1994)
E. Fernandez-Rodriguez, M. Lopez-Raton, P. Andujar, I.M. Martinez-Silva, C. Cadarso-Suarez, F.F. Casanueva, I. Bernabeu, Epidemiology, mortality rate and survival in a homogeneous population of hypopituitary patients. Clin. Endocrinol. (Oxf) 78, 278–284 (2013)
M. Regal, C. Paramo, S.M. Sierra, R.V. Garcia-Mayor, Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin. Endocrinol. (Oxf) 55, 735–740 (2001)
F. Kelestimur, Sheehan’s syndrome. Pituitary 6, 181–188 (2003)
H.J. Schneider, I. Kreitschmann-Andermahr, E. Ghigo, G.K. Stalla, A. Agha, Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA 298, 1429–1438 (2007)
F. Tanriverdi, H. Senyurek, K. Unluhizarci, A. Selcuklu, F.F. Casanueva, F. Kelestimur, High risk of hypopituitarism after traumatic brain injury: a prospective investigation of anterior pituitary function in the acute phase and 12 months after trauma. J. Clin. Endocrinol. Metab. 91, 2105–2111 (2006)
F. Tanriverdi, H. Ulutabanca, K. Unluhizarci, A. Selcuklu, F.F. Casanueva, F. Kelestimur, Three years prospective investigation of anterior pituitary function after traumatic brain injury: a pilot study. Clin. Endocrinol. (Oxf) 68, 573–579 (2008)
L. De Marinis, A. Fusco, A. Bianchi, G. Aimaretti, M.R. Ambrosio, C. Scaroni, S. Cannavo, C. Di Somma, F. Mantero, E.C. degli Uberti, G. Giordano, E. Ghigo, Hypopituitarism findings in patients with primary brain tumors 1 year after neurosurgical treatment: preliminary report. J. Endocrinol. Invest 29, 516–522 (2006)
H.L. Sheehan, The frequency of post-partum hypopituitarism. J. Obstet. Gynaecol. Br. Commonw. 72, 103–111 (1965)
A.A. Toogood, W.D. Ryder, C.G. Beardwell, S.M. Shalet, The evolution of radiation-induced growth hormone deficiency in adults is determined by the baseline growth hormone status. Clin. Endocrinol. (Oxf) 43, 97–103 (1995)
R. Abs, B.A. Bengtsson, E. Hernberg-Stahl, J.P. Monson, J.P. Tauber, P. Wilton, C. Wuster, GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin. Endocrinol. (Oxf) 50, 703–713 (1999)
L.A.S. Elumir-Mamba, A.A. Andag-Silva, J.S. Fonte, L.B. Mercado-Asis, Clinical profile and etiology of hypopituitarism at the University of Santo Tomas Hospital. Philipp J Intern Med 48, 23–27 (2010)
F. Kelestimur, P. Jonsson, S. Molvalilar, J.M. Gomez, C.J. Auernhammer, R. Colak, M. Koltowska-Haggstrom, M.I. Goth, Sheehan’s syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in K. Eur. J. Endocrinol. 152, 581–587 (2005)
N. Kurtulmus, S. Yarman, Hyponatremia as the presenting manifestation of Sheehan’s syndrome in elderly patients. Aging Clin. Exp. Res. 18, 536–539 (2006)
F. Tanriverdi, K. Unluhizarci, M. Kula, M. Guven, F. Bayram, F. Kelestimur, Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan’s syndrome. Growth Horm.IGF.Res. 15, 231–237 (2005)
G. Aimaretti, M.R. Ambrosio, C. Di Somma, M. Gasperi, S. Cannavo, C. Scaroni, A. Fusco, P. Del Monte, E. De Menis, S. Rovere, S. Benvenga, E.C. degli Uberti, L. De Marinis, G. Lombardi, G. Giordano, E. Ghigo, Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. J. Clin. Endocrinol. Metab. 90, 6085–6092 (2005)
M. Bondanelli, M.R. Ambrosio, A. Carli, A. Bergonzoni, A. Bertocchi, M.C. Zatelli, S. Ceruti, D. Valle, N. Basaglia, E.C. degli Uberti, Predictors of pituitary dysfunction in patients surviving ischemic stroke. J. Clin. Endocrinol. Metab. 95, 4660–4668 (2010)
F. Tanriverdi, K. Unluhizarci, B. Coksevim, A. Selcuklu, F.F. Casanueva, F. Kelestimur, Kickboxing sport as a new cause of traumatic brain injury-mediated hypopituitarism. Clin. Endocrinol. (Oxf) 66, 360–366 (2007)
F. Tanriverdi, A.T. Dagli, Z. Karaca, K. Unluhizarci, A. Selcuklu, F.F. Casanueva, F. Kelestimur, High risk of pituitary dysfunction due to aneurysmal subarachnoid haemorrhage: a prospective investigation of anterior pituitary function in the acute phase and 12 months after the event. Clin. Endocrinol. (Oxf) 67, 931–937 (2007)
F. Tanriverdi, K. Unluhizarci, I. Kocyigit, I.S. Tuna, Z. Karaca, A.C. Durak, A. Selcuklu, F.F. Casanueva, F. Kelestimur, Brief communication: pituitary volume and function in competing and retired male boxers. Ann. Intern. Med. 148, 827–831 (2008)
F. Tanriverdi, A. De Bellis, H. Teksahin, E. Alp, A. Bizzarro, A.A. Sinisi, G. Bellastella, V.A. Paglionico, A. Bellastella, K. Unluhizarci, M. Doganay, F. Kelestimur, Prospective investigation of pituitary functions in patients with acute infectious meningitis: is acute meningitis induced pituitary dysfunction associated with autoimmunity? Pituitary 15, 579–588 (2012)
A. Tsiakalos, I.D. Xynos, N.V. Sipsas, G. Kaltsas, Pituitary insufficiency after infectious meningitis: a prospective study. J. Clin. Endocrinol. Metab. 95, 3277–3281 (2010)
F. Tanriverdi, K. Unluhizarci, F. Kelestimur, Pituitary function in subjects with mild traumatic brain injury: a review of literature and proposal of a screening strategy. Pituitary 13, 146–153 (2010)
H.J. Schneider, G. Aimaretti, I. Kreitschmann-Andermahr, G.K. Stalla, E. Ghigo, Hypopituitarism. Lancet 369, 1461–1470 (2007)
F. Tanriverdi, A. Agha, G. Aimaretti, F.F. Casanueva, F. Kelestimur, M. Klose, B.E. Masel, A.M. Pereira, V. Popovic, H.J. Schneider, Manifesto for the current understanding and management of traumatic brain injury-induced hypopituitarism. J. Endocrinol. Invest. 34, 541–543 (2011)
B.M. Arafah, Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J. Clin. Endocrinol. Metab. 62, 1173–1179 (1986)
M.E. Molitch, D.R. Clemmons, S. Malozowski, G.R. Merriam, M.L. Vance, Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 1587–1609 (2011)
S. Benvenga, T. Vigo, R.M. Ruggeri, D. Lapa, B. Almoto, F. LoGiudice, M. Longo, A. Blandino, A. Campenni, S. Cannavo, F. Trimarchi, Severe head trauma in patients with unexplained central hypothyroidism. Am. J. Med. 116, 767–771 (2004)
Conflict of interest
The authors report no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tanriverdi, F., Dokmetas, H.S., Kebapcı, N. et al. Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from pituitary study group database. Endocrine 47, 198–205 (2014). https://doi.org/10.1007/s12020-013-0127-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-0127-4